Advertisement

Pharmacy

Novo Nordisk and United Laboratories International’s subsidiary, United Biotechnology Co. have entered into a potentially $2 billion license agreement for UBT251, a glucagon triple-receptor agonist in early stage clinical development for obesity, Type 2 diabetes and other diseases.  Novo Nordisk…

Richmond-based Virginia Commonwealth University is launching an accelerated program during the fall that allows students to earn both a Bachelor of Science in pharmaceutical sciences and a Doctor of Pharmacy degree in seven years instead of eight.  The program aims…

Effective March 20, Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics.  Optum Rx said the new pharmacy payment models are in response to price increases set by brand name drug manufacturers.  “With this…

Advertisement

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their greatest lesson from 2024. The 6 executives featured in this article are all speaking at the Becker’s Healthcare Spring Chief Pharmacy Officer Summit, April 30…

Health systems can cut costs and enhance patient care by evaluating their 340B drug purchases, according to a March 19 report from Pharmacy Practice News.  Samuel Lewis, PharmD, pharmacy business manager at Indianapolis-based Eskenazi Health, said a recent routine 340B…

Optum Rx, the pharmacy benefit manager under UnitedHealth Group, is set to eliminate prior authorization requirements for approximately 80 prescription drugs in an effort to simplify access to medications for patients with chronic conditions.  The changes are expected to reduce…

Cambridge, Mass.-based Sarepta Therapeutics reported the first known death from its Duchenne muscular dystrophy gene therapy treatment. The patient was a young man who suffered acute liver failure after being treated with Elevidys, according to a March 18 company news…

Advertisement